Trial Profile
TRIBIK (adsorbed diphtheria-purified pertussis-tetanus combined vaccine) Drug Use Surveillance
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2022
Price :
$35
*
At a glance
- Drugs Adsorbed-diphtheria-purified-pertussis-tetanus-combined-vaccine-BIKEN/Mitsubishi-Tanabe-Pharma (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Adverse reactions
- 06 Feb 2018 New trial record